Susceptibility of mycobacteria to fusidic acid

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
S E HoffnerG Källenius

Abstract

Fusidic acid was shown to be effective in vitro against 30 clinical isolates of Mycobacterium tuberculosis at concentrations of 32-64 mg/l, concentrations which are readily achieved in serum. All but one of 17 Mycobacterium avium complex strains were resistant to fusidic acid at concentrations up to 64 mg/l. However, synergistic effects were shown for 11 of the 17 strains when fusidic acid was combined with ethambutol. Five of the strains were fully susceptible to the combination of fusidic acid (64 mg/l) and ethambutol (4 mg/l). It is suggested that fusidic acid should be evaluated clinically as a potential supplementary drug for treatment of mycobacterial infections.

References

Oct 1, 1977·British Journal of Clinical Pharmacology·R WiseM Mitchard
Oct 10, 1987·Lancet·V FaberM Malkovsky
Sep 1, 1989·The Journal of Antimicrobial Chemotherapy·S E HoffnerG Källenius
May 1, 1988·Diagnostic Microbiology and Infectious Disease·S E Hoffner
Oct 1, 1987·The Journal of Antimicrobial Chemotherapy·D S Reeves
Nov 1, 1986·Reviews of Infectious Diseases·L S YoungM S Gottlieb
May 1, 1981·Journal of Clinical Microbiology·S H SiddiqiG Middlebrook
May 5, 1962·Lancet·W GODTFREDSENL TYBRING
Mar 10, 1962·Nature·W O GODTFREDSENL TYBRING
Nov 7, 1963·Nordisk medicin·P EFFERSOE

❮ Previous
Next ❯

Citations

Aug 1, 1994·International Journal of Antimicrobial Agents·V St Georgiev
Jan 1, 1994·International Journal of Antimicrobial Agents·V S Georgiev
Oct 21, 1999·International Journal of Antimicrobial Agents·P Collignon, J Turnidge
Feb 14, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Barbro Olsson-LiljequistGöran Kronvall
Jul 1, 1992·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·K FuurstedV Faber
Jan 1, 1992·Antimicrobial Agents and Chemotherapy·S G FranzblauE B Harris
Jul 1, 1994·Antimicrobial Agents and Chemotherapy·S G FranzblauT P Gillis
Feb 15, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C Cicek-SaydamA Bilgic
May 11, 2016·Annals of the American Thoracic Society·Ioana D OlaruRudolf Rumetshofer
Dec 1, 1996·Journal of Natural Products·C L CantrellS G Franzblau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.